SINK SIDE
NOTESSKIN-CARE DECISIONPRACTICAL CALL

U.S. ROUTINE CONTEXT · PRACTICAL CALL

Evaluate stretch-mark claims during pregnancy or weight change

Compare what products can plausibly do for comfort or appearance without promising prevention.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Moisturize stretch marks without buying prevention promises

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

  • A product cannot guarantee that stretch marks will not develop.
  • Pregnancy-related use requires product-specific safety context, not a blanket “natural” claim.

WHAT WE ARE NOT CLAIMING

  • The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Moisturize stretch marks without buying prevention promises

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

A product cannot guarantee that stretch marks will not develop.

The full protocol, comparator, primary criteria, sample size and profile, dispersion, and complete report are often not public.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. Health Products Compliance GuidanceU.S. Federal Trade Commission
  6. 21 CFR Part 740 — Cosmetic Product Warning StatementsOffice of the Federal Register / eCFR
  7. FDA Adverse Event Monitoring System (AEMS)U.S. Food and Drug Administration
  8. Striae distensae (stretch marks): from evidence to clinical practiceKorgavkar et Wang
  9. Topical preparations for preventing stretch marks in pregnancyBrennan et al.